Predictors of Bipolar Disorder Risk Among Patients Currently Treated
Medscape News - Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory Bipolar mood disorders among Polish psychiatric outpatients treated for major depression. J Affect Disord. 2005;84:141-147.
Source: www.medscape.com
FDA Approves AstraZeneca's SEROQUEL(R) For Bipolar Depression
PR Newswire - Food and Drug Administration (FDA) has approved SEROQUEL(R) (quetiapine fumarate) for the treatment of patients with Bipolar I disorder is characterized by one or more manic or mixed episodes, often with episodes of major depression, whereas
Source: sev.prnewswire.com
Click here for more information about depression treatment center depression treatment center
<< Home